SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-18-016465
Filing Date
2018-06-13
Accepted
2018-06-13 20:40:38
Documents
1
Period of Report
2018-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3136
  Complete submission text file 0000899243-18-016465.txt   4803
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35558 | Film No.: 18897920